For instance, EGFR (epidermal growth factor receptor) mutation testing using ctDNAs was approved as a companion in vitro diagnostic, while ctDNA testing has been required for the pre-analytical and analytical phase in the other cancer [38,39,40]. This evidence concerns the gene EGFR and cancer.